The Non-Alcoholic Steatohepatitis (NASH) market is expected to undergo significant change and growth over the next 10 years across the seven major pharmaceutical markets (7MM; US, France, Germany, Italy, Spain, UK, and Japan). In this webinar, GlobalData will analyze the current NASH treatment landscape and provide detailed insights into the market dynamics of this newly recognized disorder. This webinar will include the evaluation of the commercial and clinical profiles of drugs in development for NASH, and their sales projections within NASH over a 2019–2029 forecast period.
Currently, the majority of physicians recommend lifestyle changes as the principal standard of care, particularly in those at early stages of their disease where mortality rates are low. Over the forecast period, GlobalData expects that due the large population and current treatment use being infrequent, there remains a significant opportunity for companies to introduce regulatory approved branded therapies which are expected to become widely used in NASH patients.
Mohammad Uddin, a Consultant at GlobalData, and Director of Epidemiology, Kasey Fu, will present the changing NASH treatment landscape between 2019 and 2029, drawing insights from GlobalData’s recently published report, Non-Alcoholic Steatohepatitis (NASH) Opportunity Analysis and Forecasts to 2029. The webinar will include insights from Key Opinion Leaders (KOLs) covering the most important unmet needs for NASH, as well as the opportunities which are likely to remain by the end of the forecast period. Tina Healy, Senior Director of Immunology at GlobalData, will moderate a Q&A session following the presentation.
Key Learning Objectives
- Learn how GlobalData expects the NASH landscape to change between 2019 and 2029 across the seven major markets (US, France, Germany, Italy, Spain, the UK and Japan).
- Gain insight on the late-stage pipeline for NASH, including which products GlobalData expects to succeed, and why.
- Learn which unmet needs KOLs identified in the NASH treatment landscape, and whether or not they are likely to be met by the current pipeline .
- Identify which companies are set to be the major players in the NASH market during the forecast period.
